TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$30 Million

Alliqua Biomedical

Follow-on Offering

Bookrunner, April 2015

Alliqua Biomedical
Confidentially Marketed Public Offering

Alliqua is a regenerative technologies company committed to restoring tissue and rebuilding lives. Through its sales and distribution network, together with its proprietary products, Alliqua offers solutions that allow clinicians to utilize the latest advances in regenerative technologies to bring improved patient outcomes to their practices.